Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.880
+0.330 (12.94%)
Oct 8, 2025, 2:21 PM EDT - Market open
Pyxis Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 10.73 | 19.47 | 9.66 | 179.29 | 274.74 | 8.08 | Upgrade |
Short-Term Investments | 78.21 | 107.46 | 109.63 | - | - | - | Upgrade |
Cash & Short-Term Investments | 88.94 | 126.93 | 119.3 | 179.29 | 274.74 | 8.08 | Upgrade |
Cash Growth | -42.88% | 6.40% | -33.46% | -34.74% | 3300.19% | -58.96% | Upgrade |
Other Receivables | - | - | - | 0.6 | - | - | Upgrade |
Receivables | 3 | - | - | 0.6 | - | - | Upgrade |
Prepaid Expenses | 6.54 | 0.76 | 1.01 | 1.31 | 1.76 | 0.01 | Upgrade |
Restricted Cash | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | - | Upgrade |
Other Current Assets | - | 3.28 | 2.82 | 3.94 | 0.7 | 0.02 | Upgrade |
Total Current Assets | 99.96 | 132.44 | 124.6 | 186.61 | 278.67 | 8.1 | Upgrade |
Property, Plant & Equipment | 20.77 | 22.14 | 24.81 | 24.77 | 1.24 | 1.94 | Upgrade |
Other Intangible Assets | 2.49 | 2.6 | 24.31 | - | - | - | Upgrade |
Other Long-Term Assets | - | - | - | - | 0.11 | 0.11 | Upgrade |
Total Assets | 123.22 | 157.18 | 173.73 | 211.38 | 280.02 | 10.15 | Upgrade |
Accounts Payable | 9.41 | 4.86 | 3.9 | 7.1 | 11.95 | 1.08 | Upgrade |
Accrued Expenses | 6.7 | 10.73 | 12.62 | 23.45 | 6.33 | 1.88 | Upgrade |
Current Portion of Leases | 1.57 | 1.45 | 1.23 | - | 0.17 | 0.62 | Upgrade |
Current Unearned Revenue | - | - | 7.66 | - | - | - | Upgrade |
Other Current Liabilities | - | 0.64 | 0.36 | 1.09 | 0.27 | 0.12 | Upgrade |
Total Current Liabilities | 17.68 | 17.68 | 25.76 | 31.63 | 18.71 | 3.69 | Upgrade |
Long-Term Leases | 17.89 | 18.75 | 20.1 | 18.92 | - | 0.17 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | 2.16 | - | - | - | Upgrade |
Total Liabilities | 35.57 | 36.43 | 48.02 | 50.56 | 18.71 | 3.85 | Upgrade |
Common Stock | 0.06 | 0.06 | 0.05 | 0.03 | 0.03 | 0 | Upgrade |
Additional Paid-In Capital | 490.65 | 484.08 | 411.82 | 373.23 | 353 | 0.1 | Upgrade |
Retained Earnings | -403.07 | -363.56 | -286.23 | -212.44 | -91.72 | -15.74 | Upgrade |
Comprehensive Income & Other | -0.01 | 0.17 | 0.06 | - | - | - | Upgrade |
Total Common Equity | 87.64 | 120.75 | 125.7 | 160.82 | 261.31 | -15.65 | Upgrade |
Shareholders' Equity | 87.64 | 120.75 | 125.7 | 160.82 | 261.31 | 6.3 | Upgrade |
Total Liabilities & Equity | 123.22 | 157.18 | 173.73 | 211.38 | 280.02 | 10.15 | Upgrade |
Total Debt | 19.46 | 20.2 | 21.33 | 18.92 | 0.17 | 0.78 | Upgrade |
Net Cash (Debt) | 69.48 | 106.73 | 97.97 | 160.37 | 274.57 | 7.3 | Upgrade |
Net Cash Growth | -48.48% | 8.95% | -38.91% | -41.59% | 3661.23% | -62.90% | Upgrade |
Net Cash Per Share | 1.13 | 1.83 | 2.46 | 4.85 | 32.33 | 7.08 | Upgrade |
Filing Date Shares Outstanding | 62.02 | 61.59 | 58.13 | 36.83 | 32.22 | 1.29 | Upgrade |
Total Common Shares Outstanding | 62.02 | 59.97 | 44.75 | 34.96 | 32.17 | 1.29 | Upgrade |
Working Capital | 82.28 | 114.76 | 98.85 | 154.98 | 259.97 | 4.41 | Upgrade |
Book Value Per Share | 1.41 | 2.01 | 2.81 | 4.60 | 8.12 | -12.13 | Upgrade |
Tangible Book Value | 85.16 | 118.15 | 101.4 | 160.82 | 261.31 | -15.65 | Upgrade |
Tangible Book Value Per Share | 1.37 | 1.97 | 2.27 | 4.60 | 8.12 | -12.13 | Upgrade |
Machinery | - | 4.19 | 4.52 | 3.28 | 1.9 | 1.36 | Upgrade |
Construction In Progress | - | - | - | 9.18 | - | - | Upgrade |
Leasehold Improvements | - | 10.74 | 10.96 | 0.53 | 0.23 | 0.21 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.